Search

everythinglearnresearchcommunity

for

Search:↓

FFA's causes may include environmental triggers and genetic factors.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Hidradenitis suppurativa treatment should be tailored to the individual, with quitting smoking being important.

Doctors need to be better prepared to assess and treat obesity in patients.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Caucasian women's hair appears thickest in their 20s, with perceived thinning after mid-30s due to both decreasing density and diameter.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Men have higher COVID-19 mortality rates than women due to biological and lifestyle factors.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

SHBG may be a useful early indicator and treatment target for PCOS.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Finasteride helps reduce heart issues and improves heart function.